OBJECTIVE: To examine the obesity candidate genes glucagon-like-peptide receptor (GLP1R), agouti signaling protein (ASIP) and the melanocortin receptors 4 and 5 (MC4R and MC5R) for DNA polymorphisms in their coding regions. SUBJECTS: Unrelated, non-diabetic Pima Indians (8 to 12 from each extreme of body fat). MEASUREMENTS: DNA sequencing within the coding regions of each gene. RESULT: Only one variant was detected, a silent substitution in exon 6 of GLP1R. CONCLUSION: The exclusion of any common amino-acid polymorphisms (allele frequency ! 0.20). implies that structural variants of these genes do not contribute to variation in the high level of obesity observed among the Pima Indians.
Introduction
A genetic component to human obesity was established in numerous studies of twins and relatives. Estimates of this component are most accurate when based upon monozygous twins reared apart, and a recent analysis of these studies concluded that 50 ± 70% of BMI variation was attributable to genetic differences. 1 The genetic basis of obesity is poorly understood, and ®nding DNA polymorphisms that affect it is ongoing. 2 The most powerful method of ®nding these putative polymorphisms is direct examination of genes for association, 3 which is feasible when the genomic structure is known. In this report, four genes (GLP1R, ASIP, MC4R, MC5R), potentially connected to obesity by studies of their function in rodents and humans, were examined for DNA codingsequence variants in Pima Indians.
Glucagon-like-peptide-1 (GLP-1), a product of proglucagon processing, inhibited feeding in rats by ICV injection and may have a role in satiety 4 or taste aversion. 5 Consistent with this possible role, the major receptor of this protein, GLP1R, is expressed in the brain. 6 Although GLP1R knockout mice seem to have normal satiety, 7 GLP-1 may still be part of a complex, undescribed network that functions to control feeding behavior through its receptor GLP1R. In humans, the agouti protein (encoded by the ASIP gene) is a high af®nity antagonist of the hypothalamic melanocortin receptor-4 (MC4R). 8 In mice, ectopic expression of agouti (A y or A vy ) is associated with the development of obesity, 9 and Mc4r knockout mice mimic the obesity of A y and A vy . 10 Mcr5 is not known to be involved in feeding but is expressed in several systemic tissues including muscle and adipose. 11, 12 Although a mechanism is unknown, genetic linkage of RFLP markers¯anking the MC5R gene to obesity in French Canadians suggests a possible role for this receptor gene in obesity. 11 
Methods
The genomic structure and intron sequences¯anking GLP1R exons were determined by sequencing of human genomic clones (Yukio Tanizawa, unpublished data). Primers to amplify the three ASIP coding exons were derived from published sequences 13 and Genbank (L37019). Additional sequence information for ampli®cation of exon 2 was kindly provided by Gregory Barsh. MC4R and MC5R are intronless genes, so primers were derived from sequence deposited at Genbank (S77415 and Z25470 Subjects were selected from a database of 416 possible subjects who had their body composition determined by hydrodensitometry. Percent body fat (%fat) was calculated according to the equations of Siri. 15 To maximize chances for detecting DNA polymorphisms that in¯uence obesity, subjects were chosen from the high and low quintiles of the %fat distribution, after adjustment of %fat for the effects of sex and age. Only one member (full blood Pima) from any single nuclear family was included. Sixteen subjects were sequenced for GLP1R, 24 for ASIP, and 20 for MC4R and MC5R.
Results and discussion
Results of this study are summarized in Table 1 . All four candidate genes were conserved in Pima Indians. Only a single polymorphic site was detected, an A ? C transversion in an AGG codon (amino acid # 170, exon 6) in GLP1R. The sample contained 9 AA, 6 AC and 1 CC genotypes. Because this substitution is silent (Arg), it was not genotyped and tested for association with obesity in a larger sample. In a different study, a variant in MC4R was detected but was rare in the surveyed population of British white subjects, and no association with obesity was found. 16 Although the level of obesity in Pima Indians is higher than other North American groups, 17 the population variability in BMI is similar (unpublished observation). We expect that an allele contributing to obesity in Pima Indians would not be rare. To assess the possibility that we missed detection of a variant, we can consider a biallelic model of a gene with a modest level of polymorphism, for example an allele frequency of 20% in either the lean or obese sample. Assuming Hardy ± Weinberg equilibrium, this would result in a heterozygote frequency of 32% and a 0.36 probability of detecting the allele by DNA sequencing of a randomly selected subject. Therefore, the chance of missing either of these two genotypes is less than 5% in a sample of either eight lean or obese subjects. If such an allele was rarer in both groups, then its detection would be more dif®cult, but its contribution to the populational variation in obesity would likely be small. This study effectively eliminates variation in the coding regions of these genes as a signi®cant source of obesity variation in the Pima Indian population.
Despite the absence of variation at these four loci altering protein sequence, they cannot be wholly excluded from contributing to obesity. Variation in the promoters, enhancers, splice junctions or transcription terminators of the genes could affect the levels of gene products and, in turn, in¯uence the accumulation of body fat.
As molecular characterization of these regions proceeds, these regions may warrant further study for effects of variation on gene expression and possible involvement in obesity. 
